BlackRock Institutional Trust’s Celgene Corp CELG Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.46B	Buy	21,253,432 +540,647	+3%	+$60.2M	0.36%	46
2016 Q3	$2.17B	Buy	20,712,785 +471,143	+2%	+$51M	0.34%	50
2016 Q2	$2B	Buy	20,241,642 +117,543	+0.6%	+$12.2M	0.32%	54
2016 Q1	$2.01B	Sell	20,124,099 -98,716	-0.5%	-$10.2M	0.33%	53
2015 Q4	$2.42B	Sell	20,222,815 -153,021	-0.8%	-$17.7M	0.4%	46
2015 Q3	$2.2B	Sell	20,375,836 -296,641	-1%	-$36.8M	0.38%	49
2015 Q2	$2.39B	Sell	20,672,477 -572,591	-3%	-$65.5M	0.38%	47
2015 Q1	$2.45B	Buy	21,245,068 +79,276	+0.4%	+$9.47M	0.38%	50
2014 Q4	$2.37B	Sell	21,165,792 -293,498	-1%	-$31M	0.38%	46
2014 Q3	$2.03B	Sell	21,459,290 -294,104	-1%	-$26.5M	0.34%	51
2014 Q2	$1.87B	Sell	21,753,394 -416,058	-2%	-$31.6M	0.31%	57
2014 Q1	$1.55B	Buy	22,169,452 +630,482	+3%	+$49.9M	0.27%	72
2013 Q4	$1.82B	Sell	21,538,970 -1,474,600	-6%	-$117M	0.32%	55
2013 Q3	$1.77B	Sell	23,013,570 -522,524	-2%	-$36.6M	0.34%	51
2013 Q2	$1.38B	Buy	+23,536,094	New	+$1.42B	0.28%	63